FDA Inspection 907479 — Taro Pharmaceuticals U.S.A., Inc.

Taro Pharmaceuticals U.S.A., Inc. — FEI 2435212

The FDA completed an inspection of Taro Pharmaceuticals U.S.A., Inc. on Dec 19, 2014 in Hawthorne, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.